Pricing

Akero

58 people · 0 jobs

‌

Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being eva... Read more

Industries

Biotechnology, Education

Headquarters

South San Francisco, United States

Employees

Links

Org chart

President & CEO

Collapse

COO & Co Founder

Chief Scientific Officer & Co-Founder

CFO & Head of Corporate Development

Chief Development Officer

VP of Regulatory Affairs

EVP And Chief Development Officer

Director, Business Operations

Chief Technical Officer

Senior Executive Coordinator And Office Manager

Board & advisors

Board Chair

Graham Walmsley

Director

Jane Pritchett Henderson

Director

Director

Seth L. Harrison

Director

Director

Director

Teams

Clinical Research and Development

12 people · 0 jobs

Financial and Accounting Team

7 people · 0 jobs

Development Team

6 people · 0 jobs

Leadership Team

6 people · 0 jobs

Quality Control Team

3 people · 0 jobs

Offices

HQ
8 people · 0 jobs
AM
+4

Similar companies

Cellares

5 followers

Tango Therapeutics

3 followers

Dyno Therapeutics

4 followers

Odyssey Therapeutics

3 followers

Gilead Sciences

171 followers

Regeneron

143 followers

Illumina

81 followers

Agilent Technologies

89 followers

Verily Life Sciences

48 followers

Alexion Pharmaceuticals

49 followers

GRAIL

30 followers

Explore companies